Joint declaration signed
WASHINGTON and TOKYO, Feb. 26 /PRNewswire-USNewswire/ -- As the voice of the global clinical outsourcing industry, the Association of Clinical Research Organizations (ACRO) had the honor of presenting before the Japan CRO Association's 15th Commemorative Symposium February 26th, 2009 in Tokyo.
ACRO Chair Derek Winstanly, MBChB, discussed "The Modern Day CRO - Expectations" and ACRO Executive Director Douglas Peddicord, Ph.D. addressed "Representing a Global Industry." Dr. Winstanly is Executive Vice President of Strategic Business Development for Quintiles Transnational, a global CRO with offices in 50 countries, including 13 in Japan.
"The drug development process and the clinical outsourcing market are becoming increasingly global in scope, bringing about a need for consistent messaging and positioning of the industry before regulators, lawmakers, research sponsors, patient groups and the public," said Dr. Peddicord.
ACRO joined with JCROA and the European CRO Federation (EUCROF) in signing The Tokyo Declaration, which outlines areas of common interest and cooperation. Tokyo Declaration - Association of Clinical Research Organizations
"The Declaration is another step toward the CRO industry speaking with a unified voice throughout the world," added Peddicord.
About ACRO The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 70,000 professionals worldwide. For more information, please visit www.acrohealth.org.
|SOURCE Association of Clinical Research Organizations|
Copyright©2009 PR Newswire.
All rights reserved